Propofol Disrupts Clear Cell Renal Cell Carcinoma Tumorigenesis by Regulating circFBXW7/miR-942 Axis

Yunfeng Huang1, Yuanbo Wu1, Shengqiang Lu1

  • 1Department of Anesthesiology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Nephron
|March 21, 2022
PubMed
Abstract

Insights

Propofol, an anesthetic, inhibits clear cell renal cell carcinoma (ccRCC) growth by regulating the circFBXW7/miR-942 pathway. This finding suggests propofol as a potential therapeutic strategy for ccRCC intervention.

Area of Science:

  • Oncology
  • Anesthesiology
  • Molecular Biology

Background:

  • Propofol exhibits anticancer properties across various cancers.
  • The specific effects and mechanisms of propofol in clear cell renal cell carcinoma (ccRCC) are not well-defined.

Purpose of the Study:

  • To investigate the anticancer effects of propofol in ccRCC.
  • To elucidate the underlying molecular mechanisms involving circular RNA FBXW7 (circFBXW7) and miR-942.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) for circFBXW7 and miR-942 expression.
  • In vitro assays (cell counting kit-8, colony formation, flow cytometry, transwell) for cell proliferation, apoptosis, migration, and invasion.
  • Western blot for protein expression (PCNA, Cleaved-caspase 3, MMP).
  • RNA pull-down, dual-luciferase reporter, and RIP assays for circFBXW7-miR-942 interaction.
  • Xenograft tumor analysis for in vivo tumorigenesis.

Main Results:

  • Propofol inhibited ccRCC cell proliferation, migration, invasion, and induced apoptosis in vitro, while impeding tumor growth in vivo.
  • Propofol increased circFBXW7 expression, which was crucial for its anticancer effects; knockdown of circFBXW7 reversed these effects.
  • circFBXW7 directly targeted miR-942, suppressing ccRCC cell malignancy.
  • Propofol decreased miR-942 expression, and its overexpression attenuated propofol's effects, indicating propofol regulates miR-942 via circFBXW7.

Conclusions:

  • Propofol suppresses ccRCC progression by modulating the circFBXW7/miR-942 axis.
  • This pathway presents a potential therapeutic strategy for human ccRCC intervention.